Evidence map›Paper›PMID 35286311›Full record

ArticlePLoS computational biology2022

A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism.

Iñigo Apaolaza, Edurne San José-Enériz, Luis V Valcarcel, Xabier Agirre, Felipe Prosper, Francisco J Planes

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Iñigo ApaolazaUniversidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, Spain.ORCID 0000-0002-8961-4513
Edurne San José-EnérizUniversidad de Navarra, CIMA Centro de Investigación de Medicina Aplicada, Pamplona, Spain.
Luis V ValcarcelUniversidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, Spain.ORCID 0000-0003-3769-5419
Xabier AgirreUniversidad de Navarra, CIMA Centro de Investigación de Medicina Aplicada, Pamplona, Spain.
Felipe ProsperUniversidad de Navarra, CIMA Centro de Investigación de Medicina Aplicada, Pamplona, Spain.ORCID 0000-0001-6115-8790
Francisco J PlanesUniversidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, Spain.ORCID 0000-0003-1155-3105
Navarre Institute of Health Research · ESUniversidad de Navarra · ES

Funding

Cancer Research UK C355/A26819
6 · The paper itself

Abstract

Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of function of either of two genes individually has limited effect in cell viability but inactivation of both genes simultaneously leads to cell death. Given the profound genomic aberrations acquired by tumor cells, which can be systematically identified with -omics data, SL is a promising concept in cancer research. In particular, SL has received much attention in the area of cancer metabolism, due to the fact that relevant functional alterations concentrate on key metabolic pathways that promote cellular proliferation. With the extensive prior knowledge about human metabolic networks, a number of computational methods have been developed to predict SL in cancer metabolism, including the genetic Minimal Cut Sets (gMCSs) approach. A major challenge in the application of SL approaches to cancer metabolism is to systematically integrate tumor microenvironment, given that genetic interactions and nutritional availability are interconnected to support proliferation. Here, we propose a more general definition of SL for cancer metabolism that combines genetic and environmental interactions, namely loss of gene functions and absence of nutrients in the environment. We extend our gMCSs approach to determine this new family of metabolic synthetic lethal interactions. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of tumor cells, elucidating cholesterol and myo-inositol depletion as potential vulnerabilities in different malignancies.

Indexed as

NeoplasmsSynthetic Lethal MutationsCell Line, TumorGenomicsHumansMetabolic Networks and PathwaysNutrientsTumor MicroenvironmentNutrients

Identifiers

PMID35286311
PMCPMC8947600
OpenAlexW4221110364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.